Literature DB >> 16492760

Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein.

Shingo Takikawa1, Ronald E Engle, Suzanne U Emerson, Robert H Purcell, Marisa St Claire, Jens Bukh.   

Abstract

GB virus B (GBV-B), which infects tamarins, is the virus most closely related to hepatitis C virus (HCV). HCV has a protein (p7) that is believed to form an ion channel. It is critical for viability. In vitro studies suggest that GBV-B has an analogous but larger protein (p13). We found that substitutions of the -1 and/or -3 residues of the putative cleavage sites (amino acid 613/614 and 732/733) abolished processing in vitro and rendered an infectious GBV-B clone nonviable in tamarins. Internal cleavage was predicted at two sites (amino acid 669/670 and 681/682), and in vitro analysis indicated processing at both sites, suggesting that p13 is processed into two components (p6 and p7). Mutants with substitution at amino acid 669 or 681 were viable in vivo, but the recovered viruses had changes at amino acid 669 and 681, respectively, which restored cleavage. A mutant lacking amino acid 614-681 (p6 plus part of p7) was nonviable. However, a mutant lacking amino acid 614-669 (p6) produced high titer viremia and acute resolving hepatitis; viruses recovered from both animals lacked the deleted sequence and had no other mutations. Thus, p6 was dispensable but p7 was essential for infectivity. The availability of a recombinant GBV-B virus containing a p7 protein with similarities to the HCV p7 will enhance the relevance of this model and will be of importance for identifying compounds that inhibit p7 function as additional therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492760      PMCID: PMC1413929          DOI: 10.1073/pnas.0511297103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Subcellular localization and topology of the p7 polypeptide of hepatitis C virus.

Authors:  Séverine Carrère-Kremer; Claire Montpellier-Pala; Laurence Cocquerel; Czeslaw Wychowski; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release.

Authors:  P Liljeström; S Lusa; D Huylebroeck; H Garoff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 3.  Mechanisms of membrane permeabilization by picornavirus 2B viroporin.

Authors:  José L Nieva; Aitziber Agirre; Shlomo Nir; Luis Carrasco
Journal:  FEBS Lett       Date:  2003-09-18       Impact factor: 4.124

4.  The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences.

Authors:  Akito Sakai; Marisa St Claire; Kristina Faulk; Sugantha Govindarajan; Suzanne U Emerson; Robert H Purcell; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

5.  Identification of signal peptide peptidase, a presenilin-type aspartic protease.

Authors:  Andreas Weihofen; Kathleen Binns; Marius K Lemberg; Keith Ashman; Bruno Martoglio
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

Review 6.  A critical role for the chimpanzee model in the study of hepatitis C.

Authors:  Jens Bukh
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

7.  Characterization of GB virus B polyprotein processing reveals the existence of a novel 13-kDa protein with partial homology to hepatitis C virus p7 protein.

Authors:  David Ghibaudo; Lisette Cohen; François Penin; Annette Martin
Journal:  J Biol Chem       Date:  2004-04-01       Impact factor: 5.157

8.  Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors.

Authors:  Helen Bright; Anthony R Carroll; Paul A Watts; Robert J Fenton
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  In vivo analysis of the 3' untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin.

Authors:  Jae-Hwan Nam; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Marisa St Claire; Jens Bukh
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology.

Authors:  James R Jacob; Kuei-Chin Lin; Bud C Tennant; Keith G Mansfield
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

View more
  15 in total

1.  Hepatitis C homolog in dogs with respiratory illness.

Authors:  Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

Review 2.  The Strange, Expanding World of Animal Hepaciviruses.

Authors:  Alex S Hartlage; John M Cullen; Amit Kapoor
Journal:  Annu Rev Virol       Date:  2016-09-29       Impact factor: 10.431

Review 3.  Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses.

Authors:  Troels K H Scheel; Peter Simmonds; Amit Kapoor
Journal:  Antiviral Res       Date:  2014-12-26       Impact factor: 5.970

4.  Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins.

Authors:  Shingo Takikawa; Ronald E Engle; Kristina N Faulk; Suzanne U Emerson; Robert H Purcell; Jens Bukh
Journal:  J Gen Virol       Date:  2009-11-11       Impact factor: 3.891

5.  Bats are a major natural reservoir for hepaciviruses and pegiviruses.

Authors:  Phenix-Lan Quan; Cadhla Firth; Juliette M Conte; Simon H Williams; Carlos M Zambrana-Torrelio; Simon J Anthony; James A Ellison; Amy T Gilbert; Ivan V Kuzmin; Michael Niezgoda; Modupe O V Osinubi; Sergio Recuenco; Wanda Markotter; Robert F Breiman; Lems Kalemba; Jean Malekani; Kim A Lindblade; Melinda K Rostal; Rafael Ojeda-Flores; Gerardo Suzan; Lora B Davis; Dianna M Blau; Albert B Ogunkoya; Danilo A Alvarez Castillo; David Moran; Sali Ngam; Dudu Akaibe; Bernard Agwanda; Thomas Briese; Jonathan H Epstein; Peter Daszak; Charles E Rupprecht; Edward C Holmes; W Ian Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

6.  Identification of GBV-D, a novel GB-like flavivirus from old world frugivorous bats (Pteropus giganteus) in Bangladesh.

Authors:  Jonathan H Epstein; Phenix-Lan Quan; Thomas Briese; Craig Street; Omar Jabado; Sean Conlan; Shahneaz Ali Khan; Dawn Verdugo; M Jahangir Hossain; Stephen K Hutchison; Michael Egholm; Stephen P Luby; Peter Daszak; W Ian Lipkin
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

7.  Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.

Authors:  Corine StGelais; Toshana L Foster; Mark Verow; Elizabeth Atkins; Colin W G Fishwick; David Rowlands; Mark Harris; Stephen Griffin
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

8.  Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck.

Authors:  Trudie Weatherford; Deborah Chavez; Kathleen M Brasky; Stanley M Lemon; Annette Martin; Robert E Lanford
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

Review 9.  Scotomas in molecular virology and epidemiology of hepatitis C virus.

Authors:  Yue Wang
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

10.  Infection of Common Marmosets with GB Virus B Chimeric Virus Encoding the Major Nonstructural Proteins NS2 to NS4A of Hepatitis C Virus.

Authors:  Shaomei Zhu; Tingting Li; Bochao Liu; Yuxia Xu; Yachun Sun; Yilin Wang; Yuanzhan Wang; Lifang Shuai; Zixuan Chen; Jean-Pierre Allain; Chengyao Li
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.